https://www.thebody.com/author/mark-mascolini

Mark Mascolini

Mark Mascolini has been writing about HIV and AIDS since the beginning of the epidemic. Peer-reviewed work he coauthored has appeared in JAIDS, Antiviral Therapy and the Journal of the International AIDS Society.

His work appears regularly on TheBodyPRO.com and the websites of the National AIDS Treatment Advocacy Project (NATAP), AVAC and the Center for AIDS, as well as in Reviews in Antiviral Therapy & Infectious Diseases.

Mascolini has published interviews with scores of leading HIV investigators, including Bernard Branson, Myron Cohen, Kevin DeCock, Anthony Fauci, Robert Grant, David Ho, Daniel Kuritzkes, Joep Lange and Mark Wainberg.

Latest by Mark Mascolini

Higher Diabetes Rate in People With HIV Highlights Importance of Prevention and Monitoring Img
News

Higher Diabetes Rate in People With HIV Highlights Importance of Prevention and Monitoring

The diabetes rate is about 4% higher in people with HIV than in the general U.S. population -- highlighting the importance of early monitoring for and prevention of diabetes.

By Mark Mascolini
Heavy Alcohol Drinking Linked to Worse HIV Disease in U.S. Veterans Img
News

Heavy Alcohol Drinking Linked to Worse HIV Disease in U.S. Veterans

We already know some of the dangers of drinking too much alcohol, but new research suggests that heavy alcohol consumption exacerbates the negative effects of HIV in people living with the virus.

By Mark Mascolini
Chance of HIV Rebounding After Successful Treatment Steadily Declining Img
News

Chance of HIV Rebounding After Successful Treatment Steadily Declining

The chance of HIV rebounding after starting and maintaining antiretroviral therapy lies close to 1% per year in certain groups living with HIV, according to a study published in The Lancet HIV.

By Mark Mascolini
Heavy Alcohol Drinking Linked to Higher Death Risk Among People With HIV Img
News

Heavy Alcohol Drinking Linked to Higher Death Risk Among People With HIV

Compared with moderate alcohol drinkers, people with self-reported or provider-reported heavy drinking ran a higher risk of death, according to a 10-year study.

By Mark Mascolini
Among Anti-HIV Drugs, Only Sustiva Has Possible Impact on Contraceptives Img
News

Among Anti-HIV Drugs, Only Sustiva Has Possible Impact on Contraceptives

Most HIV drugs have little or no impact on the effectiveness of hormonal contraceptives, with the possible exception of Sustiva (efavirenz).

By Mark Mascolini
Fracture Risk Doubled in 50- to 59-Year-Old Men With HIV Img
News

Fracture Risk Doubled in 50- to 59-Year-Old Men With HIV

Compared with a similar group of HIV-negative men, 50- to 59-year-old men with HIV in a large U.S. study had a doubled risk of fractured bones.

By Mark Mascolini
Prior Pneumonia, Smoking, and Drinking Explain Higher Lung Cancer Risk With HIV Img
Substance Use

Prior Pneumonia, Smoking, and Drinking Explain Higher Lung Cancer Risk With HIV

A past pneumonia episode largely explained a higher risk of lung cancer in people living with HIV, according to a large study in California. Smoking and alcohol abuse also contributed to the higher risk.

By Mark Mascolini
Ten Things Every HIV-Positive Smoker Should Know Img
Substance Use

Ten Things Every HIV-Positive Smoker Should Know

Quitting smoking can certainly be a tough commitment to make. For HIV-positive smokers who may be struggling to quit, here are 10 things to know.

By Mark Mascolini for The Center for AIDS Information & Advocacy
Promo Image
News

New WHO ART Advice for Pregnant Women -- Three ARVs at Any CD4

A third World Health Organization (WHO) option to treat HIV-positive pregnant women -- and to prevent mother-to-child transmission (MTCT) of HIV -- calls for starting triple antiretroviral (ARV) therapy (ART) for all women as soon as they test positi...

By Mark Mascolini for The Black AIDS Institute
Promo Image
News

How Far Can You Knock Down HIV?: An Interview with David D. Ho, MD

Introduction The primary infection experiment Not just "math and modeling" Thinking ahead with anti-HIV regimens "Not a time to pull back" on quest for new drugs The eradication wager References

When attempting to write a pithy preambl...

By Mark Mascolini for International Association of Physicians in AIDS Care